Description

Sudorega (pregabalin) hard capsules 75 mg. №28

Ingredients

Each hard capsule contains 75 mg of pregabalin.

Dosage

The recommended dosage is as prescribed by a healthcare professional.

Indications

Sudorega (pregabalin) is indicated for the treatment of neuropathic pain, fibromyalgia, and as an adjunctive therapy for adults with partial seizures.

Contraindications

Do not use Sudorega (pregabalin) if you are allergic to pregabalin or any other ingredients in the capsules.

Directions

Swallow the capsules whole with water. Do not crush or chew them.

Scientific Evidence

Pregabalin, the active ingredient in Sudorega, exerts its effects by binding to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system. This mechanism reduces the release of neurotransmitters such as glutamate, noradrenaline, and substance P, which are involved in pain signaling.

Several clinical trials have demonstrated the efficacy of pregabalin in the management of neuropathic pain and fibromyalgia. A study by Arnold et al. (2017) showed that pregabalin significantly reduced pain scores and improved quality of life in patients with fibromyalgia compared to placebo.

Additional Information

Pregabalin has a favorable safety profile with the most common side effects being dizziness and somnolence. It is important to follow the prescribed dosage to minimize the risk of adverse effects.

Patients should be monitored for signs of suicidal ideation or unusual changes in behavior while taking pregabalin, especially at the beginning of treatment or after dose adjustments.